Oragenics prices public offering of common stock

Oragenics ( NYSE: OGEN ) on Tuesday said it has entered into a placement agency agreement for the purchase and sale of 1.1M shares of common stock at $1.00 per share.

The gross proceeds of the offering are anticipated to be about $1.1M before deducting placement agent fees and other estimated offering expenses payable by the company. The company intends to use the net proceeds from the offering to fund the continued development of its ONP-002 product candidate and for general corporate purposes and working capital.

The offering is expected to close on or about June 26, 2024. Press release. More on Oragenics Oragenics climbs 9% amid Phase 2 study, business updates Oragenics files 10K and provides company update Financial information for Oragenics.